Evidence map›Paper›PMID 29769706›Full record

ArticleScientific reports2018

Red algal extracts from Plocamium lyngbyanum and Ceramium secundatum stimulate osteogenic activities in vitro and bone growth in zebrafish larvae.

Matthew A Carson, John Nelson, M Leonor Cancela, Vincent Laizé, Paulo J Gavaia, Margaret Rae, Svenja Heesch, Eugene Verzin, Christine Maggs, Brendan F Gilmore and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Metabolic bone disorders and the promise of marine osteoactive compounds.Cellular and molecular life sciences : CMLS · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matthew A CarsonSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom. mcarson16@qub.ac.uk.ORCID 0000-0003-2733-939X
John NelsonSchool of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
M Leonor CancelaCentre of Marine Sciences (CCMAR), University of Algarve, Campus de Gambelas, Faro, Portugal.
Vincent LaizéDepartment of Biomedical Sciences and Medicine, University of Algarve, Campus de Gambelas, Faro, Portugal.ORCID 0000-0001-9565-9198
Paulo J GavaiaAlgarve Biomedical Center (ABC), Universidade do Algarve, Campus de Gambelas, 8005-139, Faro, Portugal.
Margaret RaeMarine Institute and Irish Seaweed Research Group, Rinville, Oranmore, Co., Galway, Ireland.
Svenja HeeschIrish Seaweed Research Group, Ryan Institute, National University of Ireland Galway, University Road, Galway, Ireland.
Eugene VerzinOrthopaedic department, Royal Victoria Hospital, Belfast, United Kingdom.
Christine MaggsFaculty of Science and Technology, Bournemouth University, Bournemouth, United Kingdom.
Brendan F GilmoreSchool of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
Susan A ClarkeSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0002-7720-5405

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Through the current trend for bioprospecting, marine organisms - particularly algae - are becoming increasingly known for their osteogenic potential. Such organisms may provide novel treatment options for osteoporosis and other musculoskeletal conditions, helping to address their large healthcare burden and the limitations of current therapies. In this study, extracts from two red algae - Plocamium lyngbyanum and Ceramium secundatum - were tested in vitro and in vivo for their osteogenic potential. In vitro, the growth of human bone marrow stromal cells (hBMSCs) was significantly greater in the presence of the extracts, particularly with P. lyngbyanum treatment. Osteogenic differentiation was promoted more by C. secundatum (70 µg/ml), though P. lyngbyanum had greater in vitro mineralisation potential. Both species caused a marked and dose-dependent increase in the opercular bone area of zebrafish larvae. Our findings therefore indicate the presence of bioactive components in P. lyngbyanum and C. secundatum extracts, which can promote both in vitro and in vivo osteogenic activity.

Indexed as

AnimalsBone DevelopmentCell DifferentiationCell ProliferationCells, CulturedHumansIn Vitro TechniquesLarvaMesenchymal Stem CellsOsteogenesisOsteoporosisPlant ExtractsPlocamiumRhodophytaZebrafishPlant Extracts

Identifiers

PMID29769706
PMCPMC5956103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.